hematological malignancies
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Target patients Patients with hematopoietic malignancies who visited HOME CARE CLINIC N-CONCEPT and joint research institutions between January 1, 2008 and February 28, 2022 are eligible. (2) Selection criteria 1.Subjects who have a definitive diagnosis of hematopoietic malignancies and have performed home-visit treatment at HOME CARE CLINIC N-CONCEPT or a joint research institution (2) Those who do not refuse to participate in this study
Exclusion criteria
Exclusion criteria: Exclusion criteria (1) Subjects with unconfirmed diagnosis of hematopoietic malignancies (2) Patients who are judged by the principal investigator to be unsuitable as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients requiring blood transfusion | — |
Contacts
HOME CARE CLINIC N-CONCEPT